Mometasone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Effects of the Direct Interaction Between Streptococcus Salivarius 24SMBc and Streptococcus Oralis 89a and the Respiratory Epithelium in Children
Condition: Allergy Interventions: Combination Product: Streptococcus salivarius 24SMBc + Sprept. oralis 89a; Combination Product: fluticasone + mometasone; Other: placebo Sponsor: Federico II University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2018 Category: Research Source Type: clinical trials

Effects of the Direct Interaction Between Streptococcus Salivarius 24SMBc and Streptococcus Oralis 89a and the Respiratory Epithelium in Children
Condition: Allergy Interventions: Combination Product: Streptococcus salivarius 24SMBc + Strept. oralis 89a; Combination Product: fluticasone + mometasone; Other: placebo Sponsor: Federico II University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Molo 1 (also referred as GSP 301-2 NS); Drug: Molo 2 (also referred as GSP 301-1 NS); Drug: Placebo nasal spray; Drug: DYMISTA nasal spray; Drug: PATANASE nasal spray Sponsor: Glenmark Pharmaceuticals Ltd. India Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2018 Category: Research Source Type: clinical trials